Diphenylmethyl (6R,7R)-3-(chloromethyl)-7-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate(CAS: 112028-91-8)

This compound requires adherence to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for classification and labeling. For manufacturing and importing purposes, it must comply with REACH regulations. FDA and EPA may also have specific requirements regarding its handling and environmental impact. Comprehensive safety data sheets (SDS) and compliant labeling are essential for regulatory compliance.

There are alternative reagents and isomers that can be used in synthesis. For instance, using 2-methyl-2-propanol as a starting material instead of its carbonyl derivative can lead to different synthetic pathways. Additionally, similar compounds with different functional groups can serve as viable alternatives, reducing the complexity and cost of synthesis.

The demand for this compound is driven by its applications in medicinal chemistry and pharmaceutical research. Market trends indicate increasing interest in developing new drugs and therapies. Research is focused on exploring its potential as an intermediate in drug synthesis and as a scaffold for novel pharmacological agents. Pricing trends suggest fluctuation based on supply-demand dynamics and production costs.

Waste containing this compound should be collected in appropriate containers, ensuring proper labeling and containment to prevent environmental contamination. Incineration is a common method for disposal, but professional waste disposal services should be sought to ensure compliance with local regulations. Environmental protection measures, such as neutralizing any hazardous components, should be implemented to minimize ecological impact.